Related Experiment Videos
A comparison of treated and untreated glaucoma suspects
M Schulzer1, S M Drance, G R Douglas
1Department of Ophthalmology and Medicine, University of British Columbia, Vancouver, Canada.
Ophthalmology
|March 1, 1991
Summary
Timolol treatment did not significantly prevent visual field defects or optic nerve damage in patients with elevated intraocular pressure (IOP). IOP levels and baseline cup-to-disc ratio influenced disease progression in untreated individuals.
Area of Science:
- Ophthalmology
- Clinical Trials
- Glaucoma Research
Background:
- Elevated intraocular pressure (IOP) is a primary risk factor for glaucoma.
- Early glaucoma detection and intervention are crucial for preserving vision.
Purpose of the Study:
- To evaluate the efficacy of timolol in preventing the progression of ocular hypertension to glaucoma.
- To identify factors influencing the progression of optic nerve damage and visual field defects.
Main Methods:
- A 6-year prospective randomized clinical trial involving 143 patients with IOP > 22 mmHg.
- Patients were assigned to either timolol treatment or no treatment.
- Endpoints included visual field defects, disc hemorrhages, and optic nerve head changes.
Main Results:
- No statistically significant difference in time to endpoint development between treated and untreated groups.
- In the untreated group, disc changes correlated with mean IOP and IOP fluctuations.
- Initial cup-to-disc ratio correlated with visual field defect progression in untreated patients.
Conclusions:
- Timolol did not demonstrate a statistically significant benefit in preventing glaucoma progression in this cohort.
- Intraocular pressure and baseline optic nerve head characteristics are important predictors of glaucoma development.